期刊文献+

影响甲真菌病预后因素的研究进展 被引量:3

Prognostic factors for onychomycosis
原文传递
导出
摘要 甲真菌病顽固难治,目前采用的治疗方法包括局部治疗、口服抗真菌药物治疗以及口服药物和局部治疗等综合疗法,但这些方法的疗效常受多种因素的影响.影响甲真菌病预后的因素主要有甲的局部因素,包括甲真菌病的临床类型、甲板生长速度、甲板厚度、甲母质受累、甲下癣菌瘤或甲下条索状损害的影响,另外还有甲的既往感染史,遗传因素,药物的选择以及糖尿病、银屑病的影响等.其中甲的局部改变是影响预后的最主要因素.充分了解影响甲真菌病的预后因素有助于临床医生确定治疗方案以及随访时间的长度,从而有助于提高甲真菌病的治愈率,改善患者生活质量. Onychomycosis is very hard to treat,and present therapeutic approaches include local treatment and oral antifungal treatment alone or in combination.Unfortunately,the treatment outcome is usually influenced by multiple factors.The prognosis of onychomycosis is mainly affected by local factors of nails,including clinical type of onychomycosis,growth rate and thickness of nail plate,involvement of nail matrix,coexistence of subungual dermatophytoma or streak-like lesions.Other prognostic factors include a history of prior nail infection,hereditary factors,choice of drugs,comorbidities such as diabetes or psoriasis,etc.Fully understanding of prognostic factors for onychomycosis can help clinicians to determine treatment protocols and length of follow-up,so as to improve recovery rate and life quality of patients with onychomycosis.
出处 《国际皮肤性病学杂志》 2015年第1期58-60,共3页 International Journal of Dermatology and Venereology
关键词 甲癣 预后 抗真菌药 Onychomycosis Prognosis Antifungal agents
  • 相关文献

参考文献19

  • 1Grover C , Khurana A . An update treatment ofonychomycosis[J]. Mycoses, 2012, 55(6): 541-551.
  • 2Szepietowski JC, Reich A. Stigmatisation in onychomycosis patients: a population-based study [Jl. Mycoses, 2009, 52(4): 343-349.
  • 3Lecha M, Effendy I, Feuilhade de Chauvin M, et al. Treatment options--development of consensus guidelines [J]. J Eur Acad Dermatol Venereal, 2005, 19(Suppl 1 ): 25-33.
  • 4Sigurgeirsson B. Prognostic factors for cure following treatment of onychomycosis [J ]. J Eur Acad Dermatol Venereol, 2010, 24 (6): 679-684.
  • 5Yu HJ, Kwon HM, Oh DH, et al. Is slow nail growth a risk factor for onychomycosis? [J]. Clin Exp Dermatol, 2004, 29 (4): 415- 418.
  • 6Scher RK, Tavakkol A, Sigurgeirsson B, et al. Onychomycosis: diagnosis and definition of cure [J]. J Am Acad Dermatol, 2007, 56(6): 939-944.
  • 7Burkhart CN, Burkhart CG, Gupta AK. Dermatophytoma: Recalcitrance to treatment because of existence of fungal biofilm [J]. J Am Acad Dermatol, 2002, 47(4): 629-631.
  • 8Zaias N, Tosti A, Rebell G, et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum [J]. J Am Acad Dermatol, 1996, 34 (2 Pt 1 ): 302-304.
  • 9Leelavathi M, Azimah MN, Kharuddin NF, et al. Prevalence of toenail onychomycosis among diabetics at a primary care facility in Malaysia [J]. Southeast Asian J Trop Med Public Health, 2013, 44(3): 479-483.
  • 10Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients [J]. Eur J Dermatol, 2000, 10 (5): 379-384.

同被引文献18

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部